Hosted on MSN22d
Multiple sclerosis symptoms at onset linked to long-term disability
The study utilized the Expanded Disability Status Scale (EDSS), a widely recognized tool for quantifying disability in MS patients. This approach allowed the researchers to correlate initial ...
Monthly Prescribing Reference24d
Tolebrutinib Gets Breakthrough Tx Status for Non-Relapsing Secondary Progressive MS
To be enrolled, participants had to have a nrSPMS diagnosis with an expanded disability status scale (EDSS) score between 3.0 and 6.5, no clinical relapses at least 24 months, and documented ...
Pharm Exec24d
FDA Grants Breakthrough Therapy Designation to Sanofi’s Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis
According to Sanofi, nrSPMS was defined at baseline as having a SPMS diagnosis with an expanded disability status scale (EDSS) between 3.0 and 6.5, no clinical relapses for the previous 24 months, and ...